Saad Shaaban is a Professor of Bio-organic Chemistry at Mansoura University in Egypt. He obtained his Ph.D. in 2011 from the School of Pharmacy at Saarland University in Germany. He has worked as a postdoctoral researcher at the Doemling’s Drug Design group at Groningen University in the Netherlands, the Wessjohann’s Bio-organic Chemistry group at the Leibniz Institute of Plant Biochemistry in Germany, the BioPeroxIL group at the University of Bourgogne in France, and the Manolikakes group at the Goethe-Universität in Frankfurt, Germany. Dr. Shaaban’s long-term vision is to bring novel drugs to patients in an indicated area of unmet medical needs (e.g., cancer and neurodegenerative diseases).